![]() Juvenescence Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
| ![]() Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | ![]() Abiogen Pharma Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases. | ![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ||
Founding Date | Founding Date 2016 | Founding Date 1988 | Founding Date 1977 | Founding Date 1997 | Founding Date N/A |
Type | Type Private | Type Public | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Dublin, IE HQ | Locations Leiden, NL HQ Leiden, NL | Locations Tourcoing, FR HQ Mouvaux, FR | Locations Pisa, IT HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US |
Employees | Employees 3310% increase | Employees 404 | Employees 901 | Employees 351 | Employees 29723% increase |
Valuation ($) | Valuation ($) 500 m | Valuation ($) 590.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $341m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit €53m (FY, 2025) |
Net income | Net income N/A | Net income $2.5m (FY, 2025) | Net income N/A | Net income N/A | Net income (€196.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 162.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 267.3m |

Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View companyMacopharma is a provider of blood transfusion and bio-sourced therapies.
View company
Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases.
View company
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company